2016
DOI: 10.1016/j.tjog.2016.06.003
|View full text |Cite
|
Sign up to set email alerts
|

Oral Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 to reduce Group B Streptococcus colonization in pregnant women: A randomized controlled trial

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
105
0
2

Year Published

2017
2017
2024
2024

Publication Types

Select...
6
4

Relationship

0
10

Authors

Journals

citations
Cited by 97 publications
(107 citation statements)
references
References 9 publications
0
105
0
2
Order By: Relevance
“…Lactobacillus rhamnosus GR-1 is bile-resistant and survives the passage through the gastrointestinal tract [3,4]. It has been found to relieve urogenital problems and urinary tract infections by colonizing intestinal and urogenital cells [5][6][7]. Most probiotics are available as over-the-counter items, and as fermented dairy products, such as yogurt and kefir [1,2].…”
Section: Introductionmentioning
confidence: 99%
“…Lactobacillus rhamnosus GR-1 is bile-resistant and survives the passage through the gastrointestinal tract [3,4]. It has been found to relieve urogenital problems and urinary tract infections by colonizing intestinal and urogenital cells [5][6][7]. Most probiotics are available as over-the-counter items, and as fermented dairy products, such as yogurt and kefir [1,2].…”
Section: Introductionmentioning
confidence: 99%
“…A study by Murina, et al (2014) reported that the use of the long term two strains of Lactobacillus species as a vaginal slow release tablet has prevented the rVVC in 86% of patients for 10 weeks, and has also resulted in the inhibition of the rVVC for 7 months after discontinuing the probiotics in 72.3% of patients [48]. The same phenomena were demonstrated by Ho, et al (2016) in pregnant women whom were colonized with vaginal and rectal Group B Streptococcus, when they were treated with two Lactobacillus strains of probiotics, it was effective in 40% of women compared to 18% in the placebo group [49]. The oral administration of multi species probiotics has shown antimicrobial activity in vitro against Candida albicans and E. coli in pre-menopausal women and the ability of probiotics to prevent uro-genital infections and inhibit epithelial cell proliferation by increasing the vagina pH after 7 days [50][51].…”
Section: Probiotics and Vaginal Infectionmentioning
confidence: 67%
“…Evidence that orally administered lactobacilli could reach the vagina came from 3 human studies (Reid et al 2001a(Reid et al , 2001b(Reid et al , 2003a) and the concept was subsequently confirmed by others (Morelli et al 2004). Of significance to pregnant women, one recent Taiwanese study has shown that ingestion of capsules containing the GR-1 and RC-14 strains reduces vaginal and rectal colonization by group B streptococci (GBS) (Ho et al 2016). GBS is a leading cause of primary neonatal sepsis, pneumonia, and meningitis in the first week of life, and a primary reason for intrapartum parenteral antibiotic prophylaxis at 35-37 weeks of gestation.…”
Section: Lactobacilli Properties and Early Evidence Of Benefits In Humentioning
confidence: 99%